facebook pixel
Our latest U.S. FDA submission reflects our dedication to advancing innovative therapies for patients with newly diagnosed #MultipleMyeloma for whom transplant is not planned. We continue to strive toward transforming outcomes for this complex disease: t.co/C88LURYRET t.co/mpu9gxz8jy
https://twitter.com/JNJInnovMed/status/1840861298235519466
Posted on Twitter/X ·

 1

 580

Credits
Suggested Credits

Credits on Gondola describe each credited role and may be incomplete. A brand or featured person is not necessarily the creator.

Tags, Events, and Projects